Lataa...
Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1
OBJECTIVE: Celastrol was recently identified as a potential novel treatment for obesity. However, the effect of Celastrol on nonalcoholic fatty liver disease (NAFLD) remains elusive. The aim of this study is to evaluate the role of Celastrol in NAFLD. METHODS: Functional studies were performed using...
Tallennettuna:
| Julkaisussa: | Mol Metab |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5220393/ https://ncbi.nlm.nih.gov/pubmed/28123944 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molmet.2016.11.002 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|